This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Dr. Martens Past Earnings Performance
Past criteria checks 2/6
Dr. Martens has been growing earnings at an average annual rate of 38%, while the Luxury industry saw earnings growing at 27.7% annually. Revenues have been growing at an average rate of 16.9% per year. Dr. Martens's return on equity is 31.9%, and it has net margins of 12.9%.
Key information
38.03%
Earnings growth rate
37.85%
EPS growth rate
Luxury Industry Growth
12.91%
Revenue growth rate
16.91%
Return on equity
31.89%
Net Margin
12.89%
Next Earnings Update
30 Nov 2023
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dr. Martens makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BMV:DOCS N Revenue, expenses and earnings (GBP Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 23
1,000
129
373
0
31 Dec 22
979
153
350
0
30 Sep 22
957
177
347
0
30 Jun 22
933
179
331
0
31 Mar 22
908
181
316
0
31 Dec 21
867
118
300
0
30 Sep 21
825
54
304
0
30 Jun 21
799
44
276
0
31 Mar 21
773
35
248
0
31 Dec 20
747
61
219
0
30 Sep 20
722
87
191
0
30 Jun 20
697
81
204
0
31 Mar 20
672
75
217
0
31 Mar 19
454
17
124
0
31 Mar 18
349
-6
94
0
31 Mar 17
291
-11
75
0
31 Mar 16
232
-12
56
0
31 Mar 15
235
0
50
0
31 Mar 14
164
-32
24
0
Quality Earnings: DOCS N has a high level of non-cash earnings.
Growing Profit Margin: DOCS N's current net profit margins (12.9%) are lower than last year (19.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DOCS N has become profitable over the past 5 years, growing earnings by 38% per year.
Accelerating Growth: DOCS N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: DOCS N had negative earnings growth (-28.9%) over the past year, making it difficult to compare to the Luxury industry average (-13%).
Return on Equity
High ROE: DOCS N's Return on Equity (31.9%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/06/14 00:24
End of Day Share Price
2023/03/17 00:00
Earnings
2023/03/31
Annual Earnings
2023/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Martens plc is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.